Sodergren MH

ORCID: 0000-0002-7141-3924 · 4 papers in corpus
other 2026
A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis-Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.70078

BACKGROUND: Although there is growing evidence supporting the use of cannabis-based medicinal products (CBMPs) for the management of chronic pain, there is a paucity of data on their effect on endometriosis-associated chronic pain. AIMS: T…

review 2026
A Scoping Systematic Review of Cannabis Use in Endometriosis
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.70081

BACKGROUND: Endometriosis, affecting 6%-10% of reproductive-age women, causes chronic pelvic pain, dysmenorrhea, and infertility. Current treatments have limitations and consequently there is rising interest in effects of cannabis on pain a…

article 2026
Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.70173

BACKGROUND: Endometriosis affects up to 10% of biological females of reproductive age. Current treatment options are limited and often unsuitable for prolonged use. Cannabis-based medicinal products (CBMPs) have emerged as an alternative fo…

2023
An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry.
Neuropsychopharmacology reports ·doi:10.1002/npr2.12403

IntroductionWhile there is increasing evidence of the effects of cannabis-based medicinal products (CBMPs) on health-related quality of life (HRQoL), a major limitation of the current literature is the heterogeneity of studied CBMPs. This s…